Long-term invasive follow-up of the everolimus-eluting bioresorbable vascular scaffold: five-year results of multiple invasive imaging modalities

Background: Invasive imaging modalities have shown restoration of vasomotion, prevention of restenosis and most importantly increase in lumen area between 6-months and 2-years after first-generation everolimus-eluting bioresorbable vascular scaffold (Absorb BVS) implantation. Our aim was to assess whether these positive findings were sustained in the long-term.